1Reaven GM.Role of insulinresistance in human disease[J]. Diabetes,1988;37(11):1595～1607
2Shen DC,Shieh SM, Fuhm T,et al.Resistance to insulinstimulated glucose uptake inpatients with hypertension[J].J Clin Endocrinol Metab,1988;66(3);580～583
3Skarfors ET,Lithell Ho,Selinus I, et al. Risk factors for the development ofhypertension:a 10 year longitudinal study in middle-age men[J].JHypertens,1991;9(3):217～23
4Modan M,Ualkin H.Hyperinsulinemia or increased sympathetic drive as links forobesity and hypertension[J].Diabetes-Care,1991;14(6):470～87
5James A,O′Hare.The Enigma of insulin resistance and hypertension[J].Am JMedicine,1988;84:505～510
6Sieglp KS,Kislighn SD.Pharmacology of losartan, an angiotensin II receptorantagonist, in animal models of hypertension[J]. J Hypertens,1995;13(suppl):515
7Nakata T, Takeda k, Hatta T,et al. Blockade of angiotensin II receptors inhibitsthe increase in blood pressure induced by insulin[J].J Cardiovascpharmacol,1998;31:248～252
8Liang C,Doherty JU, Faillace R,et al.Insulin infusion in conscious dogs: effects onsystemic and coronary hemodynamics,regional blood flows and plasma catecholamines[J].JClin Invest,1982;69:1321～36
9Rowe JW,Young JB, Minaker Kl,et al. Effects of insulin and glucose infusions onsympathetic nervous activity in normal man[J]. Diabetes,1981;30:219～225
10Moan A, Risanger, Eide I.The effect of angiotensin II receptor blockade on insulinsensitivity and sympathetic nervous system activity in primary hypertension[J]. BloodPress,1994;3:185～8
